3 completed. 3 Phase 1, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 3 | Completed 3 |
| Phase 2 | 1 | Completed 1 |
Follow Multiple Sclerosis, Primary Progressive: new trials by email Literature Review of Multiple Sclerosis, Primary Progressive trials Research Report on Multiple Sclerosis, Primary Progressive
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| PET Study of PIPE-791 in Healthy Volunteers and Volunteers With PrMS and IPF PIPE-791 - Idiopathic Pulmonary Fibrosis (IPF), Idiopathic Pulmonary Fibrosis | Phase 1 | Completed | Contineum Therapeutics | 16 | 2024-12-09 | 2025-08-06 |
| Intranasal Insulin for Improving Cognitive Function in Multiple Sclerosis Insulin, Placebo (Sterile diluent) - Multiple Sclerosis, Relapsing-Remitting, Multiple Sclerosis, Secondary Progressive | Phase 1 / Phase 2 | Completed | Johns Hopkins University | 105 | 2017-12-01 | 2023-03-10 |
| Open-label Study of Liothyronine in MS liothyronine - Multiple Sclerosis, Relapsing-Remitting, Multiple Sclerosis, Secondary Progressive | Phase 1 | Completed | Johns Hopkins University | 20 | 2015-07-01 | 2018-02-12 |
Multiple Sclerosis, Chronic Progressive (3) · Multiple Sclerosis, Relapsing-Remitting (2) · Autoimmune Diseases (1) · Autoimmune Diseases of the Nervous System (1) · Demyelinating Autoimmune Diseases, CNS (1) · Demyelinating Diseases (1) · Idiopathic Pulmonary Fibrosis (1) · Immune System Diseases (1) · Multiple Sclerosis (1) · Nervous System Diseases (1) · Neuroinflammatory Diseases (1) · Pathologic Processes (1) · Sclerosis (1)
Chronic Disease (3) · Disease Attributes (3) · Pathological Conditions, Signs and Symptoms (3) · Autoimmune Diseases (2) · Autoimmune Diseases of the Nervous System (2) · Demyelinating Autoimmune Diseases, CNS (2) · Demyelinating Diseases (2) · Immune System Diseases (2) · Multiple Sclerosis (2) · Nervous System Diseases (2) · Pathologic Processes (2) · Brain Diseases (1) · Central Nervous System Diseases (1) · Inflammation (1) · Leukoencephalopathies (1)
Insulin (1) · Triiodothyronine (1)
Johns Hopkins University (2) · Contineum Therapeutics (1)
United States (2) · United Kingdom (1)
Scott Newsome, DO (2) · Ellen Mowry, MD, MCR (1) · Stephen Huhn, MD (1)